DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView ® System, that uses multi-spectral imaging and AI algorithms ...
Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...
Hosted on MSN
MDAI: DeepView awarded $32 million from BARDA
Spectral AI, Inc. (NASDAQ: MDAI) reported 2025 results on March 24 th after the market close. Highlights since the company’s third quarter release include the elevation of Vincent Capone to Chief ...
DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
DALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and ...
DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Image source: The Motley Fool. Spectral AI (NASDAQ:MDAI) advanced its DeepView commercialization strategy with regulatory and financial milestones, including a timely FDA de novo submission and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results